Freedom Capital Markets Initiates Coverage On Doximity with Buy Rating, Announces Price Target of $31

Benzinga Newsdesk www.benzinga.com Neutral 67.7%

Neg 0% Neu 67.7% Pos 0%

Freedom Capital Markets analyst Gene Mannheimer initiates coverage on Doximity (NYSE:DOCS) with a Buy rating and announces Price Target of $31.